Y0002197

Deferasirox for system suitability CRS

European Pharmacopoeia (EP) Reference Standard

• Sinónimos: Deferasirox, 4-[3,5-bis(2-Hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
• Fórmula empírica (notación de Hill): C₂₁H₁₅N₃O₄
• Número de CAS: 201530-41-8
• Peso molecular: 373.36
• Número MDL: MFCD09951804

Propiedades

• grado: pharmaceutical primary standard
• fabricante / nombre comercial: EDQM
• aplicaciones: pharmaceutical
• temp. de almacenamiento: −20°C
• cadena SMILES: N2(N\C(=C4\C=CC=CC\4=O)\N\C\2=C3\C=CC=CC\3=O)c1ccc(cc1)C(=O)O
• InChI: 1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,22-23H,(H,27,28)/b19-15-,20-16+
• Clave InChI: FMSOAWSKCWYLBB-VBGLAJCLSA-N

Descripción

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Acciones bioquímicas o fisiológicas

Deferasirox is an orally available iron chelator used clinically for reduction of chronic iron overload in diseases such as β-thalassemia.

Orally available iron chelator

Envase

Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit EDQM reference substance catalogue.

Otras notas

EP issued certificate and SDS can be found here.

Sales restrictions may apply.

Información de seguridad

• Pictogramas: GHS07,GHS09
• Palabra de señalización: Warning
• Frases de peligro: H302,H400
• Consejos de prudencia: P264 - P270 - P273 - P301 + P312 - P391 - P501
• Clasificaciones de peligro: Acute Tox. 4 Oral - Aquatic Acute 1
• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3